SynCore Biotechnology Co. Ltd. (4192) signed an international contract with UK-based retinal imaging company Epipole Ltd. for the Taiwanese distribution rights of fundus cameras epiCam® M and epiCam® C. Epipole will provide the devices and equip SynCore with the necessary materials for the successful market approval and commercialization of these products. Consequently Taiwan will become the first country in Asia to provide products from the epiCam® family. The epiCam® products are hand-held digital fundus cameras designed as an aid to diagnosis and management of ophthalmic diseases. Extremely lightweight, with no battery to charge, they include the particular feature of capturing pictures or extracting them later from the recorded retinal videos. Both epiCam® M and epiCam® C are included in the IAPB (International Agency for the Prevention of Blindness) Standard List of curated quality eye care equipment.
Craig Robertson, CEO of Epipole Ltd stated that he is delighted to be working with Syncore Bio introducing the epiCam® technology into Taiwan to reduce avoidable blindness.
General Manager of SynCore, Dr. Muh-Hwan Su expressed high excitement in the collaboration towards adding the epiCam® products to SynCore’s ophthalmic devices group.